{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:51:16Z","timestamp":1776775876658,"version":"3.51.2"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114328","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T13:34:49Z","timestamp":1675431289000},"page":"114328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Aryltetralin lignans from Hyptis brachiata inhibiting T lymphocyte proliferation"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-6591","authenticated-orcid":false,"given":"Morris","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Winker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Marisa","family":"Zimmermann-Klemd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5941-7623","authenticated-orcid":false,"given":"Nino","family":"Sperisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahabir P.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9214-0339","authenticated-orcid":false,"given":"Pablo N.","family":"Solis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-273X","authenticated-orcid":false,"given":"Matthias","family":"Hamburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-6516","authenticated-orcid":false,"given":"Olivier","family":"Potterat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-0342","authenticated-orcid":false,"given":"Carsten","family":"Gr\u00fcndemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114328_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/bs.ircmb.2018.05.008","article-title":"T Lymphocytes and autoimmunity","volume":"341","author":"Khan","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114328_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaci.2015.10.023","article-title":"Alterations in immune function with biologic therapies for autoimmune disease","volume":"137","author":"Her","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2023.114328_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0162-3109(00)00186-7","article-title":"Immunosuppressive drugs: the first 50 years and a glance forward","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.biopha.2023.114328_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3892\/br.2017.909","article-title":"Drug development: lessons from nature (review)","volume":"6","author":"Mathur","year":"2017","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.biopha.2023.114328_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrneurol.2009.139","article-title":"Predicting responders to therapies for multiple sclerosis","volume":"5","author":"R\u00edo","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.114328_bib6","first-page":"1463","article-title":"Avoiding non-responders to cardiac resynchronization therapy: a practical guide","volume":"38","author":"Daubert","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2023.114328_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2023.114328_bib8","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.114328_bib9","first-page":"5","article-title":"Usos populares de Lamiaceae en Venezuela","volume":"18","author":"Vel\u00e1zquez","year":"1995","journal-title":"Acta Bot\u00e1nica Venezu\u00e9lica"},{"key":"10.1016\/j.biopha.2023.114328_bib10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/acs.jnatprod.2c00146","article-title":"Combining activity profiling with advanced annotation to accelerate the discovery of natural products targeting oncogenic signaling in melanoma","volume":"2022","author":"Hell","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.114328_bib11","first-page":"254","article-title":"Volatile compounds of analysis of Eriope crassipes, Hyptis conferta, H. dilatata, H. brachiata, H. suaveolens and H. mutabilis (Lamiaceae)","volume":"13","author":"Tafurt-Garcia","year":"2014","journal-title":"Bol. Latinoam. Y. Del. Caribe Plantas Med. Y. Arom\u00e1t"},{"key":"10.1016\/j.biopha.2023.114328_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/stem.5530120502","article-title":"The activation antigen CD69","volume":"12","author":"Ziegler","year":"1994","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2023.114328_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113225","article-title":"Subtribe Hyptidinae (Lamiaceae): a promising source of bioactive metabolites","volume":"264","author":"Bridi","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.114328_bib14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/np070124q","article-title":"Sesquiterpenoids and cytotoxic lignans from the bark of Libocedrus chevalieri","volume":"70","author":"Zhang","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.114328_bib15","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/jssc.201800530","article-title":"Preparative separation of flavone dimers from Dysosma versipellis by counter-current chromatography: trifluoroacetic acid as a solvent system modifier","volume":"41","author":"Yang","year":"2018","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.biopha.2023.114328_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0031-9422(95)00195-D","article-title":"Kazmi, Antifungal aryltetralin lignans from leaves of Podophyllum hexandrum","volume":"40","author":"Atta-ur-Rahman","year":"1995","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2023.114328_bib17","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.bmcl.2011.04.036","article-title":"Three new cytotoxic aryltetralin lignans from Sinopodophyllum emodi","volume":"21","author":"Sun","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2023.114328_bib18","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/0031-9422(82)85261-8","article-title":"Three methylated flavones from Thymus vulgaris","volume":"21","author":"Van Den Broucke","year":"1982","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2023.114328_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0031-9422(00)95197-5","article-title":"Flavonoid constituents of Stachys aegyptiaca","volume":"30","author":"El-Ansari","year":"1991","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2023.114328_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1021\/acs.jnatprod.7b00924","article-title":"Phenolic constituents isolated from the twigs of Cinnamomum cassia and their potential neuroprotective effects","volume":"81","author":"Liu","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.114328_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.microc.2016.09.002","article-title":"Determination of podophyllotoxin and related aryltetralin lignans by HPLC\/DAD\/MS from Lamiaceae species","volume":"130","author":"Brand\u00e3o","year":"2017","journal-title":"Microchem. J."},{"key":"10.1016\/j.biopha.2023.114328_bib22","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1021\/acs.jnatprod.6b00428","article-title":"Structural and biochemical characterization of the interaction of tubulin with potent natural analogues of podophyllotoxin","volume":"79","author":"Ant\u00fanez-Mojica","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.114328_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/rheumatology\/28.5.418","article-title":"The effect of CPH 82 on the growth of human lymphocytes in vitro. Definition of cytobiological action","volume":"28","author":"Dahlqvist","year":"1989","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2023.114328_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-2006-960110","article-title":"Suppression of mitogen-induced proliferation of human peripheral blood lymphocytes by plant lignans","volume":"57","author":"Hirano","year":"1991","journal-title":"Planta Med"},{"key":"10.1016\/j.biopha.2023.114328_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/08923978509026477","article-title":"CPH-86, a highly purified podophyllotoxin, efficiently suppresses in vivo and in vitro immune responses","volume":"7","author":"Brigati","year":"1985","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.biopha.2023.114328_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/03009748809098808","article-title":"Proresid in the long-term treatment of rheumatoid arthritis","volume":"17","author":"Lysholm","year":"1988","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib27","first-page":"179","article-title":"Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82)","volume":"11","author":"Truedsson","year":"1993","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF02231790","article-title":"Effect of CPH82 in rheumatoid arthritis. Accumulation of bone marrow cells in mitosis and clinical response","volume":"12","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"1993","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/030097400750001888","article-title":"Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon\u00ae) in patients with rheumatoid arthritis","volume":"29","author":"Carlstr\u00f6m","year":"2000","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/030097400447723","article-title":"CPH 82 (Reumacon\u00ae) in refractory inflammatory arthritis","volume":"29","author":"Gudmundsd\u00f3ttir","year":"2000","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/rheumatology\/39.3.316","article-title":"A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis","volume":"39","author":"Lerndal","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2023.114328_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/rheumatology\/33.4.327","article-title":"Cell cycle effects of the anti-rheumatic agent CPH82","volume":"33","author":"Dahlqvist","year":"1994","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2023.114328_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/28.2.124","article-title":"Podophyllum derivatives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis","volume":"28","author":"Larsen","year":"1989","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2023.114328_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-2008-1043548","article-title":"CPH 82 (Reumacon\u00ae): A new and promising basic therapy in rheumatoid arthritis","volume":"24","author":"Svensson","year":"1999","journal-title":"Aktuelle Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib35","first-page":"405","article-title":"Inhibition of ConA-induced proliferate response in human lymphocytes by podophyllotoxin and a detergent, Tween80","volume":"6","author":"Mansson","year":"1988","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2008-1047442","article-title":"Podophyllotoxin therapy in rheumatoid arthritis: a clinical open dose-response study","volume":"15","author":"Meske","year":"1990","journal-title":"Aktuelle Rheumatol."},{"key":"10.1016\/j.biopha.2023.114328_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/1359-6446(96)10028-3","article-title":"Podophyllotoxin derivatives: drug discovery and development","volume":"1","author":"Bohlin","year":"1996","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2023.114328_bib38","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1039\/C5RA23516B","article-title":"Aryldihydronaphthalene-type lignans from Bursera fagaroides var. fagaroides and their antimitotic mechanism of action","volume":"6","author":"Ant\u00fanez-Mojica","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2023.114328_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/molecules24010008","article-title":"Lignans from Bursera fagaroides affect in vivo cell behavior by disturbing the tubulin cytoskeleton in zebrafish embryos","volume":"24","author":"Ant\u00fanez-Mojica","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.114328_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ardp.19943270309","article-title":"Antineoplastic and antiviral activities of podophyllotoxin related lignans","volume":"327","author":"Gordaliza","year":"1994","journal-title":"Arch. Pharm. (Weinh. )."},{"key":"10.1016\/j.biopha.2023.114328_bib41","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2174\/0929867013372292","article-title":"Aryltetralin lignans: chemistry, pharmacology and biotransformations","volume":"8","author":"Botta","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114328_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-2006-959660","article-title":"Antineoplastic and antiviral activities of some cyclolignans","volume":"59","author":"San Feliciano","year":"1993","journal-title":"Planta Med"},{"key":"10.1016\/j.biopha.2023.114328_bib43","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/np50100a011","article-title":"Cytotoxic constituents from Hyptis verticillata","volume":"56","author":"Novelo","year":"1993","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.114328_bib44","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/jm00179a014","article-title":"Structure-antitubulin activity relationships in steganacin congeners and analogs. Inhibition of tubulin polymerization in vitro by (\u00b1)-isodeoxypodophyllotoxin","volume":"23","author":"Zavala","year":"1980","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114328_bib45","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/jm960023h","article-title":"Immunosuppressive cyclolignans","volume":"39","author":"Gordaliza","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114328_bib46","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0968-0896(96)00158-7","article-title":"Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents","volume":"4","author":"Ter Haar","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114328_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejmech.2012.10.026","article-title":"Lignopurines: a new family of hybrids between cyclolignans and purines. Synthesis and biological evaluation","volume":"58","author":"\u00c1ngeles Castro","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114328_bib48","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1016\/j.bmcl.2009.05.093","article-title":"Antitumor activity of deoxypodophyllotoxin isolated from Anthriscus sylvestris: induction of G2\/M cell cycle arrest and caspase-dependent apoptosis","volume":"19","author":"Yong","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2023.114328_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1081\/IPH-100102570","article-title":"Podophyllotoxin lignans enhance IL-1\u03b2 but suppress TNF-\u03b1 mRNA expression in LPS-treated monocytes","volume":"23","author":"Pugh","year":"2001","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.biopha.2023.114328_bib50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF01540981","article-title":"Inhibition of tumor necrosis factor-alpha (TNF-\u03b1) and interleukin-1 beta (IL-1\u03b2) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative","volume":"14","author":"Gan","year":"1994","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.biopha.2023.114328_bib51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/08923973.2022.2077216","article-title":"Synergistic immunosuppressive effect of hispidulin and nepetin mixtures on human T lymphocytes","volume":"44","author":"Thitilertdecha","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.biopha.2023.114328_bib52","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.intimp.2009.03.006","article-title":"Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts","volume":"9","author":"Chicca","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.114328_bib53","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1039\/D2NP00028H","article-title":"Biosynthesis, total synthesis, and pharmacological activities of aryltetralin-type lignan podophyllotoxin and its derivatives","volume":"39","author":"Shen","year":"2022","journal-title":"Nat. Prod. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:53:56Z","timestamp":1776772436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":53,"alternative-id":["S0753332223001166"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114328","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aryltetralin lignans from Hyptis brachiata inhibiting T lymphocyte proliferation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114328"}}